Purpose

The purpose of this study is to find out whether an 8-week digital health promotion program called COBRA is a safe and practical (feasible) option for older adults with cancer/OAC.

Conditions

Eligibility

Eligible Ages
Over 65 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

Older Adult Patients with Cancer - Are within 1 year of completion of primary therapy for cancer OR have a diagnosis of metastatic cancer; 1. For the purpose of this study, primary therapy is defined as treatment of curative intent, first-line or later, from which the individual is advancing to active surveillance or follow-up with or without maintenance therapy. 2. Individuals with metastatic cancer may be included provided they have stable disease or better per most recent restaging exam at time of enrollment. i. Patients with stable metastatic bony disease at most recent restaging exam and a score of 0-2 on the Functional Pain Scale (FPS69; Appendix 18) are eligible. The PI will consult with the Rehab Med co-PI for FPS scores of 3 or greater, by patient request or PI discretion. ii. Patients with symptomatic visceral metastases will be evaluated on a case-by-case basis at time of enrollment. - Are aged 65 years and older, with no upper age limit; - ECOG PS 0-3 or Karnofsky PS greater than or equal to 40; - Can read and speak English; - Self-report access to internet connection sufficient to support videoconferencing. Clinicians - Licensed clinician (MD, RN, APP) with an interest in the care of older adults with cancer.

Exclusion Criteria

Older Adult Patients with Cancer - Have any cognitive impairment, neurologic, musculoskeletal, or other comorbid condition (as assessed by their provider) that would prevent the individual from engaging with the digital health coaching program or complete study assessments or engage in progressive intensity levels of physical activity - Have a neurologic, musculoskeletal, or other comorbid condition that would impede their ability to safely engage in progressive intensity levels of physical activity (as assessed by their provider). Patients with metastatic disease and suspected interim progression since last restaging exam will be referred back to their primary oncology care team for evaluation prior to enrollment. - Have activity restrictions post-surgery at the time of enrollment Clinicians No expected exclusions

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Supportive Care
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Older Adult Patients/OAP
Older Adult Patients with Cancer are within 1 year of completion of primary therapy for cancer OR have a diagnosis of metastatic cancer;
  • Behavioral: Cancer, Older adults, Balance and Resistance Activities
    The COBRA intervention is delivered as a web-based application through an iPad configured to allow access only to the study application and Zoom videoconferencing icons during the trial.
    Other names:
    • COBRA

Recruiting Locations

Memorial Sloan Kettering Monmouth (Consent only)
Middletown, New Jersey 07748
Contact:
Kristen Fessele, PhD, RN
646-449-1076

Memorial Sloan Kettering Bergen (Consent Only)
Montvale, New Jersey 07645
Contact:
Kristen Fessele, PhD, RN
646-449-1076

Memorial Sloan Kettering Suffolk-Commack (Consent Only)
Commack, New York 11725
Contact:
Kristen Fessele, PhD, RN
646-449-1076

Memorial Sloan Kettering Westchester (Consent only)
Harrison, New York 10604
Contact:
Kristen Fessele, PhD, RN
646-449-1076

Memorial Sloan Kettering Cancer Center (All Protocol Activites)
New York, New York 10065
Contact:
Kristen Fessele, PhD, RN
646-449-1076

Memorial Sloan Kettering Nassau (Consent Only)
Uniondale, New York 11553
Contact:
Kristen Fessele, PhD, RN
646-449-1076

More Details

NCT ID
NCT07011862
Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

Kristen Fessele, PhD, RN
646-449-1076
fesselek@mskcc.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.